Andrey I. Bakulev, Alexey V. Samtsov, Evgeny V. Sokolovskiy, Muza M. Kokhan, Marianna M. Khobeish, Vladislav R. Khairutdinov, . . . Arina V. Zinkina-Orikhan. (2022). Efficacy and safety profile of 2-year netakimab treatment in patients with moderate-to-severe plaque psoriasis in terms of the randomized double-blind placebo-controlled BCD-085-7/PLANETA clinical trial. State Scientific Center of Dermatovenereology and Cosmetology.
Chicago Style (17th ed.) CitationAndrey I. Bakulev, et al. Efficacy and Safety Profile of 2-year Netakimab Treatment in Patients with Moderate-to-severe Plaque Psoriasis in Terms of the Randomized Double-blind Placebo-controlled BCD-085-7/PLANETA Clinical Trial. State Scientific Center of Dermatovenereology and Cosmetology, 2022.
MLA (9th ed.) CitationAndrey I. Bakulev, et al. Efficacy and Safety Profile of 2-year Netakimab Treatment in Patients with Moderate-to-severe Plaque Psoriasis in Terms of the Randomized Double-blind Placebo-controlled BCD-085-7/PLANETA Clinical Trial. State Scientific Center of Dermatovenereology and Cosmetology, 2022.